The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
Open accessAbstract
SARS-CoV-2 has resulted in a global pandemic and shutdown economies around the world. Sequence analysis indicates that the novel coronavirus (CoV) has an insertion of a furin cleavage site (PRRAR) in its spike protein. Absent in other group 2B CoVs, the insertion may be a key factor in the replication and virulence of SARS-CoV-2. To explore this question, we generated a SARS-CoV-2 mutant lacking the furin cleavage site (ΔPRRA) in the spike protein. This mutant virus replicated with faster kinetics and improved fitness in Vero E6 cells. The mutant virus also had reduced spike protein processing as compared to wild-type SARS-CoV-2. In contrast, the ΔPRRA had reduced replication in Calu3 cells, a human respiratory cell line, and had attenuated disease in a hamster pathogenesis model. Despite the reduced disease, the ΔPRRA mutant offered robust protection from SARS-CoV-2 rechallenge. Importantly, plaque reduction neutralization tests (PRNT 50 ) with COVID-19 patient sera and monoclonal antibodies against the receptor-binding domain found a shift, with the mutant virus resulting in consistently reduced PRNT 50 titers. Together, these results demonstrate a critical role for the furin cleavage site insertion in SARS-CoV-2 replication and pathogenesis. In addition, these findings illustrate the importance of this insertion in evaluating neutralization and other downstream SARS-CoV-2 assays. Importance: As COVID-19 has impacted the world, understanding how SARS-CoV-2 replicates and causes virulence offers potential pathways to disrupt its disease. By removing the furin cleavage site, we demonstrate the importance of this insertion to SARS-CoV-2 replication and pathogenesis. In addition, the findings with Vero cells indicate the likelihood of cell culture adaptations in virus stocks that can influence reagent generation and interpretation of a wide range of data including neutralization and drug efficacy. Overall, our work highlights the importance of this key motif in SARS-CoV-2 infection and pathogenesis. Article Summary: A deletion of the furin cleavage site in SARS-CoV-2 amplifies replication in Vero cells, but attenuates replication in respiratory cells and pathogenesis in vivo. Loss of the furin site also reduces susceptibility to neutralization in vitro .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
An Infectious cDNA Clone of SARS-CoV-2
Xie, X., Muruato, A., Lokugamage, K. G., Narayanan, K., Zhang, X., Zou, J., Liu, J., Schindewolf, C., Bopp, N. E., Aguilar, P. V., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.004 · Cited by 647
Self-citationA high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Muruato, A. E., Fontes-Garfias, C. R., Ren, P., Garcia-Blanco, M. A., Menachery, V. D., Xie, X., & Shi, P.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17892-0 · Cited by 319
Self-citation
Research works printed but not linked: 33
- Gralinski, L.E. & Menachery, V.D. Return of the Coronavirus: 2019-nCoV. Viruses 12(2020). · DOI · Paper page
- 10.1016/S1473-3099(20)30120-1 · DOI · Paper page
- 10.1056/NEJMoa2001017 · DOI · Paper page
- 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- Gao, Z. , et al. A Systematic Review of Asymptomatic Infections with COVID-19. J Microbiol Immunol Infect (2020).
- 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y · DOI · Paper page
- 10.1126/science.abb7269 · DOI · Paper page
- 10.1016/j.tim.2015.06.003 · DOI · Paper page
- 10.1016/j.antiviral.2020.104742 · DOI · Paper page
- 10.1016/S0006-8993(99)01909-5 · DOI · Paper page
- 2019, Furin-mediated protein processing in infectious diseases and cancer, Clin Transl Immunology, 8, e1073, 10.1002/cti2.1073 · DOI · Paper page
- 10.1128/JVI.00074-08 · DOI
- 10.1038/nature17200 · DOI · Paper page
- 10.1371/journal.ppat.1007236 · DOI · Paper page
- 10.1128/JVI.02520-12 · DOI · Paper page
- 2012, Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms, Cytokine, 59, 556, 10.1016/j.cyto.2012.06.206 · doi:10.1016/j.cyto.2012.06.206
- 10.1038/s41586-020-2012-7 · DOI · Paper page
- 10.1073/pnas.2009799117 · DOI · Paper page
- 10.1186/s13073-020-00763-0 · DOI · Paper page
- 10.1128/JVI.01490-13 · DOI
- 10.1371/journal.ppat.0030005 · DOI · Paper page
- 10.1128/JVI.02520-12 · DOI · Paper page
- 10.1128/mBio.00165-13 · DOI · Paper page
- 10.1128/JVI.00818-08 · DOI
- 10.1128/JVI.03571-13 · DOI · Paper page
- van Tol, S. , et al. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection. Journal of virology 94(2020). · DOI
- 10.1016/j.jmb.2015.06.011 · DOI
- 10.1093/bioinformatics/bty560 · DOI · Paper page
- 10.1093/bioinformatics/btp352 · DOI · Paper page
- 10.1101/gr.209601.116 · DOI · Paper page
- 10.1093/bioinformatics/btq033 · DOI · Paper page
- 10.1093/nar/gky427 · DOI · Paper page
- 10.1093/nar/gkw1132 · DOI · Paper page
Cited by
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Self-citationSARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Wang, M.-Y., Zhao, R., Gao, L.-J., Gao, X.-F., Wang, D.-P., & Cao, J.-M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587269 · Cited by 874
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Dejnirattisai, W., Zhou, D., Ginn, H. M., Duyvesteyn, H. M. E., Supasa, P., Case, J. B., Zhao, Y., Walter, T. S., Mentzer, A. J., Liu, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.032 · Cited by 371
“In most SARS-CoV-2 sequences, a furin protease cleavage site is inserted between the S1 and S2 subunits, and mutation of the cleavage site attenuates disease in animal models (Johnson et al., 2020).”
Ripperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C., Weinkauf, C. C., Bime, C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.004 · Cited by 341
Gobeil, S. M.-C., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Manne, K., Stalls, V., Kopp, M. F., Henderson, R., Edwards, R. J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108630 · Cited by 332
Peacock, T. P., Brown, J. C., Zhou, J., Thakur, N., Sukhova, K., Newman, J., Kugathasan, R., Yan, A. W. C., Furnon, W., De Lorenzo, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.31.474653 · Cited by 256
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · doi:10.1101/2021.05.22.21257658 · Cited by 2,888
“(22) P681R is at the S1/S2 cleavage site and studies have suggested that strains with mutations at that site may have increased replication, leading to higher viral loads and increased transmission.(23) Immunogenicity data have not yet been reported for the B.”
BackgroundSARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
Bailey, A. L., Dmytrenko, O., Greenberg, L., Bredemeyer, A. L., Ma, P., Liu, J., Penna, V., Winkler, E. S., Sviben, S., Brooks, E., et al. (2021) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2021.01.002 · Cited by 193
Self-citationFurin cleavage sites naturally occur in coronaviruses
Wu, Y., & Zhao, S. (2021) · Stem Cell Research · doi:10.1016/j.scr.2020.102115 · Cited by 117
Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites
Liu, X., Wu, Q., & Zhang, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649314 · Cited by 32
“Thus, presence of a furin cleavage site in S protein is crucial for replication (Papa et al., 2021), pathogenesis, and transmission of SARS-CoV-2 (Johnson et al., 2020).”
BackgroundMartin, D. P., Weaver, S., Tegally, H., San, E. J., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · doi:10.1101/2021.02.23.21252268 · Cited by 291
Self-citation
Metadata
- Authors
- Johnson, B. A., Xie, X., Kalveram, B., Lokugamage, K. G., Muruato, A., Zou, J., Zhang, X., Juelich, T., Smith, J. K., Zhang, L., Bopp, N., Schindewolf, C., Vu, M., Vanderheiden, A., Swetnam, D., Plante, J. A., Aguilar, P., Plante, K. S., Lee, B., Weaver, S. C., Suthar, M. S., Routh, A. L., Ren, P., Ku, Z., An, Z., Debbink, K., Shi, P. Y., Freiberg, A. N., & Menachery, V. D.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-08-26
- OpenAlex
- W3080115946
- Cited by
- 187
- References
- 3
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.